Medical Weight Loss for Wilkes-Barre, Pennsylvania Residents
Wilkes-Barre, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month, serving Wilkes-Barre through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Wilkes-Barre Residents Choose New Hope Weight Loss
We made New Hope easy to start without making it less serious. A Wilkes-Barre patient can go from first visit to a physician-approved plan without insurance paperwork, prior authorizations, or a single drive to an office. The $119 review with Dr. Anjmun Sharma is flat, the medication price is published, and the whole thing happens by telehealth. Low friction to begin, real medicine once you do, the same standard everyone in Pennsylvania gets.
If you are searching for medical weight loss in Wilkes-Barre, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.
Think of our Costa Mesa clinic as your weight-loss provider even though you live in Wilkes-Barre, because telehealth delivers the same physician-led program to Pennsylvania without asking you to leave home. We care for patients throughout downtown Wilkes-Barre and the Wyoming Valley of Luzerne County. Your semaglutide or tirzepatide travels in insulated cold-pack packaging to keep it stable on the way to Wilkes-Barre, even on warm Pennsylvania afternoons.
Because your care happens by telehealth, there is no waitlist to clear and most Wilkes-Barre patients can have their physician visit scheduled within the same week. Your compounded semaglutide or tirzepatide ships directly to your Wilkes-Barre address in an insulated cold-pack box, so it stays stable in transit. Pennsylvania is one of the most populous states in the country, and New Hope Weight Loss serves patients across it by secure telehealth from our Costa Mesa, California clinic.
GLP-1 Weight Loss Programs Available
Semaglutide 90-Day Metabolic Reset, from $166/mo
Most Wilkes-Barre patients start here. Semaglutide shares its active ingredient with Wegovy and Ozempic, and in branded-drug trials people lost an average of 15 to 17 percent of body weight. Our program runs $499 for 90 days, with Dr. Sharma adjusting your dose each month by telehealth. Results vary, and compounded semaglutide is not FDA-approved or brand-identical.
Tirzepatide, from $233/mo
Tirzepatide works on two hunger pathways at once, GLP-1 and GIP. In trials of the branded drug, qualified patients reached up to 22.5 percent body-weight loss, which is a high-dose figure and not typical. It shares its active ingredient with Mounjaro and Zepbound.
$119 physician review. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, with no surcharge for treating you in Wilkes-Barre by telehealth.
How Telehealth Works for Wilkes-Barre
Step 1: The quiz. Tell us about your health history, current weight, and goals through a quick online intake.
Step 2: The video visit. Dr. Sharma reviews your intake and meets you by secure video, usually within 48 hours, to discuss whether compounded semaglutide or tirzepatide is a fit. Results vary from person to person.
Step 3: Delivery. A state-licensed 503(a) pharmacy ships your medication to your Wilkes-Barre address in cold-pack packaging.
Step 4: Follow-ups. You stay in touch by video as you progress.
Frequently Asked Questions, Wilkes-Barre
Can people from Wilkes-Barre get treated by New Hope Weight Loss?
Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Wilkes-Barre, Pennsylvania. Whether you are in downtown Wilkes-Barre and the Wyoming Valley of Luzerne County or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.
Do Wilkes-Barre patients ever have to come into the office?
Never. Care is delivered entirely through telehealth, which means Wilkes-Barre residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Wilkes-Barre inside cold-pack packaging that holds the right temperature in transit.
What is the cost breakdown for Wilkes-Barre?
You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Wilkes-Barre.
What areas of Wilkes-Barre do you serve?
We serve patients from across Wilkes-Barre by telehealth, including downtown Wilkes-Barre and the Wyoming Valley of Luzerne County.
Who qualifies for the program in Wilkes-Barre?
Eligibility for Wilkes-Barre patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Wilkes-Barre, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.